Introduction
Thyrotoxicosis is a clinical syndrome that results from high concentration of thyroid hormones, and has multiple etiologies. Graves' disease (GD) is the most common cause of thyrotoxicosis in the world, and has a population prevalence of 1-2%. 1) Painless thyroiditis (PT) is regarded as a variant of postpartum thyroiditis and of chronic autoimmune thyroiditis (Hashimoto's thyroiditis). It is characterized by rapidly developing and transient thyrotoxicosis, sometimes followed by hypothyroidism, and then recovery. 2, 3) In Korea, the treatment of choice for GD is antithyroid drugs (ATDs).
Most cases of PT spontaneously improved. Therefore, it is important to accurately differentiate GD from PT in order for patients to receive the proper treatment. The prevalence of PT varies in between countries, ranging from 0 to 20%. [4] [5] [6] In Korea, there is no official report on the prevalence of PT. In the present study, we determined the frequency of PT in patients with thyrotoxicosis and evaluated the usefulness of 99m Technetium ( 99m Tc) thyroid scan in differentiating between PT and GD. 
Materials and Methods
We reviewed medical records of all thyrotoxic patients who were observed by a doctor from September Fig. 2 . The mean FT4 level of Graves' disease was higher than painless thyroiditis. The normal range of FT4 was 0.93-1.7 ng/dL. Three of 30 patients showed very high level of FT4 in PT and 5 of 59 patients showed highest level of FT4 in Graves' disease. Fig. 3 . Individual serum total T3/free T4 ratios in Graves' disease and painless thyroiditis. Total T3/free T4 ratio in patients with Graves' disease was significantly (p=0.044) higher than that in patients with painless thyroiditis. 60-90% positivity in GD. 8, 9) The second generation or 3rd generation TBII assay shows positive reaction in 90-100% of patients with GD. [10] [11] [12] In this study, we used the RIA method with porcine TSH receptors that showed 100% specificity and 62% sensitivity. Some investigators [13] [14] [15] reported that 6-15% of patients with PT had positive TBII. Therefore, TBII may not be a reliable marker to differentiate GD from PT.
Previous studies reported that the total T3/FT4 ratio was useful to differentiate12 GD from PT. [16] [17] [18] Lee et al. 16) reported that the sensitivity and specificity of total T3/FT4 ratio were 75.5% and 70.3%, respectively, which was similar to what was seen in this study (sensitivity 77.0% and specificity 60%). But there was a lot of overlap between GD and PT (Fig. 3) . Therefore, it cannot accurately differentiate GD from PT. 99m Tc has several advantages, including short halflife (6 hours), short residence time in the gland, and absence of β-emission. TPOAb for detection of autoimmune thyroid disease. 25) But, in this study, TGAb is equally or more frequently positive in autoimmune thyroid disease compared to TPOAb.
Conclusion
PT accounted for a very high proportion of thyrotoxicosis in this study. All patient parameters tested such as age, sex, goiter size or nature, level of FT4, TPOAb or TGAb, and TBII cannot effectively differentiate GD from PT. Therefore, it may be useful to order routine thyroid scan in all thyrotoxic patients except in pregnant or lactating women.
Key Message
1. Painless thyroiditis accounted for a high proportion of thyrotoxicosis in Korea.
2. Routine thyroid scan may be needed to differentiate between Graves' disease and painless thyroiditis.
